𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy

✍ Scribed by Efemwonkiekie W. Iyamu; Renee Cecil; Leslie Parkin; Gerald Woods; Kwaku Ohene-Frempong; Toshio Asakura

Book ID
108673456
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
142 KB
Volume
131
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Reticulocyte parameters and hemoglobin F
Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy
✍ R. Borba; C.S.P. Lima; H.Z.W. Grotto πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 127 KB

## Abstract Hemoglobin F (HbF) is an effective inhibitor of HbS polymerization. Hydroxyurea (HU) is used to increase HbF synthesis and improve the clinical course of sickle cell disease (SCD) patients. We studied a series of laboratory parameters concerning HbF production and reticulocyte response,